Title |
Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer’s Disease
|
---|---|
Published in |
CNS Drugs, November 2018
|
DOI | 10.1007/s40263-018-0581-x |
Pubmed ID | |
Authors |
Jacoline C. Bouvy, Pall Jonsson, Diana O’Rourke, Antonella Santuccione Chadha, Niklas Hedberg, Amr Makady, Entela Xoxi, Christine Gispen-de Wied, Anja Schiel, Raj Long, John Gallacher |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 17% |
Luxembourg | 2 | 17% |
Australia | 1 | 8% |
United States | 1 | 8% |
Unknown | 6 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 10 | 83% |
Practitioners (doctors, other healthcare professionals) | 1 | 8% |
Scientists | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 41 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 11 | 27% |
Student > Master | 6 | 15% |
Other | 2 | 5% |
Student > Bachelor | 2 | 5% |
Librarian | 1 | 2% |
Other | 4 | 10% |
Unknown | 15 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 10 | 24% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 10% |
Neuroscience | 2 | 5% |
Nursing and Health Professions | 2 | 5% |
Social Sciences | 2 | 5% |
Other | 6 | 15% |
Unknown | 15 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2021.
All research outputs
#2,077,057
of 25,134,448 outputs
Outputs from CNS Drugs
#152
of 1,385 outputs
Outputs of similar age
#45,791
of 450,058 outputs
Outputs of similar age from CNS Drugs
#4
of 16 outputs
Altmetric has tracked 25,134,448 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,385 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,058 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 16 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.